Nakisa A, Sempere L, Chen X, Qu L, Woldring D, Crawford H
ChemMedChem. 2024; 19(24):e202400491.
PMID: 39230966
PMC: 11648843.
DOI: 10.1002/cmdc.202400491.
Boelaars K, Rodriguez E, Huinen Z, Liu C, Wang D, Springer B
Commun Biol. 2024; 7(1):430.
PMID: 38594506
PMC: 11003967.
DOI: 10.1038/s42003-024-06087-8.
Rashidijahanabad Z, Ramadan S, OBrien N, Nakisa A, Lang S, Crawford H
Angew Chem Int Ed Engl. 2023; 62(47):e202309744.
PMID: 37781858
PMC: 10842512.
DOI: 10.1002/anie.202309744.
Matsumoto Y, Ju T
Cancers (Basel). 2023; 15(14).
PMID: 37509200
PMC: 10377354.
DOI: 10.3390/cancers15143536.
Pinto D, Parameswaran R
Cancers (Basel). 2023; 15(13).
PMID: 37444377
PMC: 10340074.
DOI: 10.3390/cancers15133266.
Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need.
Liou G, Byrd C
Cancers (Basel). 2023; 15(9).
PMID: 37173913
PMC: 10177101.
DOI: 10.3390/cancers15092446.
Role of tumor cell sialylation in pancreatic cancer progression.
Marciel M, Haldar B, Hwang J, Bhalerao N, Bellis S
Adv Cancer Res. 2023; 157:123-155.
PMID: 36725107
PMC: 11342334.
DOI: 10.1016/bs.acr.2022.07.003.
Altered glycosylation in pancreatic cancer and beyond.
Lumibao J, Tremblay J, Hsu J, Engle D
J Exp Med. 2022; 219(6).
PMID: 35522218
PMC: 9086500.
DOI: 10.1084/jem.20211505.
AMIGO2 contained in cancer cell-derived extracellular vesicles enhances the adhesion of liver endothelial cells to cancer cells.
Izutsu R, Osaki M, Nemoto H, Jingu M, Sasaki R, Yoshioka Y
Sci Rep. 2022; 12(1):792.
PMID: 35039535
PMC: 8763894.
DOI: 10.1038/s41598-021-04662-1.
Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways.
Weitzenfeld P, Bournazos S, Ravetch J
J Clin Invest. 2019; 129(9):3952-3962.
PMID: 31424423
PMC: 6715388.
DOI: 10.1172/JCI128437.
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.
Engle D, Tiriac H, Rivera K, Pommier A, Whalen S, Oni T
Science. 2019; 364(6446):1156-1162.
PMID: 31221853
PMC: 6705393.
DOI: 10.1126/science.aaw3145.
Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis.
Liang J, Liang Y, Gao W
Onco Targets Ther. 2016; 9:3113-25.
PMID: 27307752
PMC: 4888715.
DOI: 10.2147/OTT.S102389.
Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.
Shi H, Li J, Fu D
J Cancer Res Clin Oncol. 2015; 142(6):1137-61.
PMID: 26250876
DOI: 10.1007/s00432-015-2024-0.
A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens.
Yoshihama N, Yamaguchi K, Chigita S, Mine M, Abe M, Ishii K
PLoS One. 2015; 10(4):e0124743.
PMID: 25923697
PMC: 4414583.
DOI: 10.1371/journal.pone.0124743.
Simple sugars to complex disease--mucin-type O-glycans in cancer.
Kudelka M, Ju T, Heimburg-Molinaro J, Cummings R
Adv Cancer Res. 2015; 126:53-135.
PMID: 25727146
PMC: 5812724.
DOI: 10.1016/bs.acr.2014.11.002.
CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure V, Liu T, Delgadillo L, Cuckler C, Tees D, Benencia F
Am J Physiol Cell Physiol. 2014; 308(1):C68-78.
PMID: 25339657
PMC: 4281670.
DOI: 10.1152/ajpcell.00094.2014.
Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.
Pochechueva T, Jacob F, Fedier A, Heinzelmann-Schwarz V
Metabolites. 2014; 2(4):913-39.
PMID: 24957768
PMC: 3901231.
DOI: 10.3390/metabo2040913.
Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?.
Selcukbiricik F, Bilici A, Tural D, Erdamar S, Soyluk O, Buyukunal E
Tumour Biol. 2013; 34(4):2233-9.
PMID: 23625655
DOI: 10.1007/s13277-013-0763-6.
Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer.
Yoshimoto K, Tajima H, Ohta T, Okamoto K, Sakai S, Kinoshita J
Oncol Rep. 2012; 28(3):791-6.
PMID: 22766603
PMC: 3583556.
DOI: 10.3892/or.2012.1896.
Regulation of the metastatic cell phenotype by sialylated glycans.
Schultz M, Swindall A, Bellis S
Cancer Metastasis Rev. 2012; 31(3-4):501-18.
PMID: 22699311
PMC: 4079276.
DOI: 10.1007/s10555-012-9359-7.